Obesity in Cardiovascular Disease Prevention and Treatment - A Topic Getting "Heavier" as We Speak [0.03%]
肥胖与心血管疾病预防及治疗——一个“日益加重”的话题
Carl J Lavie,Robert A Hegele,Paul Poirier et al.
Carl J Lavie et al.
A Well-Built Risk Model in Takayasu Arteritis: Strengths Acknowledged, Gaps Remain [0.03%]
承认优势，但仍存在差距的巨细胞动脉炎风险模型
Yusuf Hoşoğlu,Nedim Kaban
Yusuf Hoşoğlu
A dedicated device for a safe aortic prosthesis crossing: the Easycross catheter [0.03%]
一种安全的主动脉假体装置：Easycross导管
Marco Bruno Ancona,Barbara Bellini,Vittorio Romano et al.
Marco Bruno Ancona et al.
Paul Poirier,Carl J Lavie,Kim Connelly
Paul Poirier
Obesity, one of the most prevalent and pressing global health challenges, has significant implications for cardiovascular (CV) disease (CVD) morbidity and mortality. Diagnostic testing for CVD is substantially affected by obesity, which aff...
Transcatheter mitral valve-in-ring implantation: not all rings are the same [0.03%]
经导管二尖瓣环内植入术：并非所有的环都一样
Yinghao Lim,Ole De Backer
Yinghao Lim
Sizing for tricuspid valve-in-valve procedures: the challenges of heavily degenerated bioprosthesis [0.03%]
三尖瓣瓣中瓣手术的尺寸选择：重度退变生物瓣膜的挑战
Quentin Liabot,Aurelia Zimmerli,Stephane Fournier et al.
Quentin Liabot et al.
Integrating the care of Metabolic Dysfunction-associated Steatotic Liver Disease into Cardiac Rehabilitation: A Multisystem Approach [0.03%]
代谢功能紊乱相关性肝脂肪变性疾病护理在心脏康复中的整合：多系统方法
Giada Sebastiani,Paolo Raggi,Giovanni Guaraldi
Giada Sebastiani
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease worldwide, affecting 1 in 3 adults and driven by the rising incidence of obesity and type 2 diabetes. MASLD is also a significant c...